Grace Therapeutics, Inc. ($GRCE)
Filing Information
| Accession Number | 0001493152-26-047473 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 17, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
71,065
Total Value
$136,177.72
P&L
+2.8% (+$3,820.33)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock, par value $0.0001 per share | โ | Oct 14, 2026 | Purchase | 11,233 | $1.93 | $21,734.73 | 2,884,522 | Indirect | By Opaleye, L.P. | View Details | |
10% Owner | Common Stock, par value $0.0001 per share | โ | Oct 15, 2026 | Purchase | 23,485 | $1.95 | $45,685.37 | 2,908,007 | Indirect | By Opaleye, L.P. | View Details | |
10% Owner | Common Stock, par value $0.0001 per share | โ | Oct 16, 2026 | Purchase | 36,347 | $1.89 | $68,757.62 | 2,944,354 | Indirect | By Opaleye, L.P. | View Details |